-
Signature
-
/s/ Dov A. Goldstein as attorney-in-fact
-
Issuer symbol
-
BIOA
-
Transactions as of
-
09 Dec 2025
-
Transactions value $
-
-$97,740
-
Form type
-
4
-
Filing time
-
11 Dec 2025, 16:21:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| RUBIN PAUL D |
Chief Medical Officer |
C/O BIOAGE LABS, INC., 5885 HOLLIS STREET, SUITE 370, EMERYVILLE |
/s/ Dov A. Goldstein as attorney-in-fact |
11 Dec 2025 |
0001210905 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BIOA |
Common Stock |
Options Exercise |
$118K |
+18K |
|
$6.57 |
18K |
09 Dec 2025 |
Direct |
F1 |
| transaction |
BIOA |
Common Stock |
Sale |
-$216K |
-18K |
-100% |
$12.00 |
0 |
09 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BIOA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-18K |
-65.73% |
$0.00 |
9.38K |
09 Dec 2025 |
Common Stock |
18K |
$6.57 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: